Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease (original) (raw)
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence
Konstantinos Vardakas
International Journal of Antimicrobial Agents, 2012
View PDFchevron_right
Vancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile Infection
Dale Gerding
Clinical Infectious Diseases
View PDFchevron_right
Extended duration vancomycin in recurrent Clostridium difficile infection: a systematic review
Madison Murphy
Therapeutic Advances in Infectious Disease, 2018
View PDFchevron_right
Prospective Observational Study Comparing Three Different Treatment Regimes in Patients with Clostridium difficile Infection
Daniela Schmid
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection
Catalin I Plesea-Condratovici
JAMA internal medicine, 2017
View PDFchevron_right
Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin
Dale Gerding
Clinical Infectious Diseases, 2012
View PDFchevron_right
Long-Term Efficacy of Oral Vancomycin Prophylaxis for the Prevention of Clostridium difficile Recurrence
Emmanuel Knight
Journal of Pharmacy Practice, 2019
View PDFchevron_right
Recurrent Clostridium difficile Disease: Epidemiology and Clinical Characteristics •
Christina Surawicz
Infection Control and Hospital Epidemiology, 1999
View PDFchevron_right
Increasing Incidence of Recurrent Clostridium Difficile Infection
FLORINA FILIP CIUBOTARU
2017
View PDFchevron_right
Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
John Finney
Clinical Infectious Diseases, 2012
View PDFchevron_right
Treatment of recurrent Clostridium difficile infection: a systematic review
MSc. Medicinal Chemistry 2020
Infection, 2014
View PDFchevron_right
Treatment of Clostridium difficile-Associated Disease
Daniel Leffler
Gastroenterology, 2009
View PDFchevron_right
A Propensity-Matched Analysis Between Standard Versus Tapered Oral Vancomycin Courses for the Management of Recurrent Clostridium difficile Infection
Chris Gentry
Open Forum Infectious Diseases, 2017
View PDFchevron_right
Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review
Louis Valiquette, Stephanie Sirard
PLoS ONE, 2014
View PDFchevron_right
Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole
Curtis Donskey
PLoS ONE, 2013
View PDFchevron_right
Multicenter, Randomized Clinical Trial To Compare the Safety and Efficacy of LFF571 and Vancomycin for Clostridium difficile Infections
Kathleen Mullane
Antimicrobial Agents and Chemotherapy, 2014
View PDFchevron_right
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections
carlotta rogati
Journal of Clinical Medicine
View PDFchevron_right
Does Extending Clostridium Difficile Treatment In Patients Who Are Receiving Concomitant Antibiotics Reduce The Rate Of Relapse
Annie Brooks
The Internet Journal of Infectious Diseases, 2016
View PDFchevron_right
Comparison of Clinical and Microbiological Response to Treatment of Clostridium difficile –Associated Disease with Metronidazole and Vancomycin
Curtis Donskey
Clinical Infectious Diseases, 2008
View PDFchevron_right
Updates in Treatment of Recurrent Clostridium difficile Infection
Tanveer Singh
Journal of Clinical Medicine Research, 2019
View PDFchevron_right
Current clostridium difficile treatments: Lessons that need to be learned from the clinical trials
Ekaterini Christina Tampaki
Human Vaccines & Immunotherapeutics, 2018
View PDFchevron_right
Clostridium difficile infection: management strategies for a difficult disease
Sahil Khanna
Therapeutic Advances in Gastroenterology, 2013
View PDFchevron_right
Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center
Mirela Flonta, Irina Filipescu, M. Lupșe
Journal of gastrointestinal and liver diseases : JGLD, 2013
View PDFchevron_right
Clostridium difficile Infections: The Continuous Challenge
Mariam Kourani
2013
View PDFchevron_right
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
Matthew Oughton
The Lancet. Infectious diseases, 2017
View PDFchevron_right
Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain
Dale Gerding
Clinical Infectious Diseases, 2012
View PDFchevron_right